Skip to main content
. 2022 Jul 5;11(3):45. doi: 10.3390/antib11030045
ADC antibody-drug conjugate
CLL chronic lymphocytic leukemia
CR1 complement receptor 1, CD35
DARA daratumumab, specific for CD38
E erythrocyte
EBV Epstein–Barr virus
FcγR Fcγ receptor
HEL hen egg lysozyme peptide
LSEC liver sinusoidal endothelial cells
MM multiple myeloma
OFA ofatumumab
RTX rituximab
TRA trastuzumab
VP viral particle